Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has issued an announcement.
ResMed Inc has filed a notice of proposed sale of securities under Rule 144, indicating the sale of 2,000 common shares with an aggregate market value of $502,860. The shares are to be sold by Peter C Farrell, a director of the company, and are scheduled for sale on December 3, 2025, on the NYSE. This transaction may impact the company’s stock liquidity and shareholding structure, potentially influencing investor perception and market dynamics.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$45.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focused on the development, manufacturing, and distribution of equipment related to sleep disorders, such as sleep apnea. The company is known for its innovative solutions in respiratory care and has a significant market presence in the medical devices sector.
Average Trading Volume: 1,247,531
Technical Sentiment Signal: Buy
Current Market Cap: A$55.41B
For detailed information about RMD stock, go to TipRanks’ Stock Analysis page.